1) Epithelial ovarian cancer
卵巢上皮性癌
1.
Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer;
MMP-2和TIMP-2基因启动子区多态性与卵巢上皮性癌关系的研究
2.
WWOX mRNA expression in epithelial ovarian cancer and its clinical significance;
WWOX mRNA在卵巢上皮性癌组织中的表达及临床意义
3.
Homozygous deletion of p15、p16 genes and its co-deletion of p15/16 genes in serum DNA of the epithelial ovarian cancer;
卵巢上皮性癌血清DNA中p15、p16基因纯合性丢失及其共丢失的研究
2) epithelial ovarian carcinoma
卵巢上皮性癌
1.
Clinical significance of serum CA125 in patients with epithelial ovarian carcinoma;
血清CA125在卵巢上皮性癌中的临床意义
2.
The Clinical and Experimental Study on Metastasis Suppressor Gene KAI1/CD82 Expression in Epithelial Ovarian Carcinoma;
肿瘤转移抑制基因KAI1/CD82在卵巢上皮性癌中表达的临床实验研究
3.
Purpose:To investigate the treatment effect and influence of cytoreductive surgery and chemotherapy on epithelial ovarian carcinoma in stage Ⅲ.
目的:探讨细胞减灭术及化疗对Ⅲ期卵巢上皮性癌的治疗效果及影响因素。
3) Ovarian epithelial cancer
卵巢上皮性癌
1.
The diagnostic value of serum level of CA125、CEA in ovarian epithelial cancer and pelvic benign masses;
血清CA125、CEA水平检测在卵巢上皮性癌及盆腔良性肿物诊断中的价值
2.
Methods:From January 1999 to December 2002, 98 cases with ovarian epithelial cancer who were treated in our hospital were reviewed.
目的:探讨影响卵巢上皮性癌复发的相关因素。
3.
Objective To report the application of FPM(5Fu、DDP、MMC)regimen in late stage ovarian epithelial cancer and the results of treatment.
目的 报告FPM化疗方案在晚期卵巢上皮性癌治疗中的应用和随访结果。
4) Ovarian epithelial carcinoma
卵巢上皮性癌
1.
Expressions of IgA,IgM,IgD and IgE in ovarian epithelial carcinoma
IgA、IgM、IgD和IgE在卵巢上皮性癌中的表达
2.
Objective We detected the expression of EG-VEGF mRNA in ovarian epithelial tumors to explore the relationship between the factor and the growth and development of ovarian epithelial carcinoma(OEC).
结果EG-VEGFmRNA在卵巢上皮性癌的表达率及相对含量均高于卵巢临界恶性上皮肿瘤及良性上皮肿瘤,差异有显著性意义(P<0。
5) Epithelial ovarian cancer
上皮性卵巢癌
1.
Expression of P53 and Survivin protein in epithelial ovarian cancer tissue;
上皮性卵巢癌组织中P53和Survivin蛋白的表达
2.
Relationship of cyclooxygenase-2 expression and chemotherapy resistance in epithelial ovarian cancer patients;
上皮性卵巢癌组织中环氧化酶-2的表达与化疗耐药的相关性研究
3.
The expression of lung resistance protein and c-erbB-2 in primary epithelial ovarian cancer and its clinical significance;
LRP与c-erbB-2在上皮性卵巢癌中的表达及临床意义
6) Ovarian epithelial cancer
上皮性卵巢癌
1.
Expression ofaFGF and its receptor FGFR-1 in ovarian epithelial cancer;
上皮性卵巢癌组织中aFGF及FGFR-1的表达及临床意义
2.
Objective To explore the expression of protein kinase B(PKB)in ovarian epithelial cancer(CAOV3) and effect of PI3K inhibitor wortmannin on the proliferation of CAOV3,and the significance of PI3K/PKB pathway in ovarian cancer.
目的检测蛋白激酶B(PKB)在上皮性卵巢癌组织中的表达,以及磷脂酰肌醇3激酶(PI3K)特异性抑制剂wortmannin对卵巢癌细胞株CAOV3细胞增殖的影响,探讨PI3K/PKB信号传导通路在卵巢癌发生发展中的意义。
3.
Objective To explore the mechanism and clinical significance of motile-relation protein (MRP-l/CD9)in ovarian epithelial cancer.
目的 探讨运动相关蛋白MRP-1/CD9在上皮性卵巢癌组织中的表达及临床意义。
补充资料:家族性卵巢癌
家族性卵巢癌
指同一家族中有两个或两个以上的一代血亲患卵巢癌。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条